FDC vs MEDICO: Stock Comparison

FDC vs MEDICO REMEDIESUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

FDC is the larger company by market capitalisation. FDC shows a lower P/E, a higher dividend yield and lower leverage, while MEDICO REMEDIES shows a higher ROE, faster revenue growth and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

FDC leads 10; MEDICO leads 3 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

FDCMEDICO

Valuation lens

What price are you paying?

Market CapContext only
₹5,576 Cr
₹329 Cr
P/E RatioFDC has the lower reading
19.05x
26.66x
P/B RatioFDC has the lower reading
2.24x
4.86x
EPSFDC has the higher reading
₹8.14
₹0.3
Book ValueContext only
₹152.64
₹9.1
Dividend YieldFDC has the higher reading
1.46%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
FDC is the larger company
₹5,576 Cr vs ₹329 Cr
P/E Ratio
FDC has a lower P/E
19.05x vs 26.66x
P/B Ratio
FDC has a lower P/B
2.24x vs 4.86x
EPS
FDC has higher earnings per share
₹8.14 vs ₹0.3
Dividend Yield
FDC has a higher dividend yield
1.46% vs 0%
Revenue Growth (TTM YoY)
MEDICO has faster revenue growth
37.5% vs 18.9%
EPS Growth (TTM YoY)
FDC has faster EPS growth
166.8% vs 36.5%
Qtr Sales Growth
FDC has stronger quarterly sales growth
1.92% vs -66.37%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricFDCMEDICO
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricFDCMEDICO
Live Price₹342.8₹39.87
Day Change0.35%0.94%
Volume1.2 L52,932
52-Week High₹527.8₹56.88
52-Week Low₹312.95₹30.22
Distance from 52W High-35.05%-29.91%

Valuation

MetricFDCMEDICO
Market Cap₹5,576 Cr₹329 Cr
P/E Ratio19.05x26.66x
P/B Ratio2.24x4.86x
EPS₹8.14₹0.3
Book Value₹152.64₹9.1
Dividend Yield1.46%0%

Growth

MetricFDCMEDICO
Revenue Growth (TTM YoY)18.9%37.5%
EPS Growth (TTM YoY)166.8%36.5%
Qtr Sales Growth1.92%-66.37%
Qtr Profit Growth0.36%-80.8%

Profitability & Leverage

MetricFDCMEDICO
ROE11.47%17.38%
ROCE11.69%15.61%
Net Margin12.96%6.36%
Operating Margin18.03%9.63%
Debt to Equity0x0.25x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricFDCMEDICO
Promoter Holding69.66%61.38%
FII Holding1.4% 1 pp0.08% 0.05 pp
DII Holding6.31% 0.02 pp0%
Public Holding22.63% 0.98 pp38.54% 0.05 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: FDC and MEDICO REMEDIES.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.